Current therapeutic options for coronavirus disease 2019 (COVID-19)—lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol

BACKGROUND: Coronavirus disease 2019 (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, first manifested in December 2019, and spread rapidly worldwide. Facing this lethal disease, there is an urgent need to develop potent therapies against SARS-CoV-2 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zai-Li, Zhong, Han, Liu, Yang-Xi, Le, Ke-Jia, Cui, Min, Yu, Yue-Tian, Gu, Zhi-Chun, Gao, Yuan, Lin, Hou-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729372/
https://www.ncbi.nlm.nih.gov/pubmed/33313272
http://dx.doi.org/10.21037/atm-20-2340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729372/
https://www.ncbi.nlm.nih.gov/pubmed/33313272
http://dx.doi.org/10.21037/atm-20-2340

Ejemplares similares